je.st
news
Arena Pharmaceuticals Announces BELVIQ (lorcaserin HCl) New Drug Submission In Canada
2013-07-03 06:56:53| drugdiscoveryonline News Articles
Arena Pharmaceuticals, Inc.announced recently that Eisai Limited (based inMississauga, Ontario), a subsidiary of Eisai Inc., has submitted a New Drug Submission (NDS) for BELVIQ™ (lorcaserin HCl) with Health Canada
Tags: canada
drug
submission
arena
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|